2009-July Archives by Subject

• Messages sorted by: [ thread ] [ author ] [ date ]
• More info on this list...

Starting: Wed Jul 1 16:41:04 2009
Ending: Fri Jul 31 18:43:01 2009
Messages: 142

• [Ip-health] (FromGeneva) WIPO stalemate: No agreement reached on genetic resources, traditional knowledge and folklore   Thiru Balasubramaniam
• [Ip-health] (IP-Watch Inside Views) Interview with Ellen 't Hoen: How to Avert the Coming Drug Access Crisis   Thiru Balasubramaniam
• [Ip-health] 47 to 11, Eshoo/Barton amendment on Biosimilars passes   James Love
• [Ip-health] : CIVIL SOCIETY OPEN LETTER TO WHO Expert Working Group on R&D Financing   PiterDe Vries
• [Ip-health] =?WINDOWS-1252?Q?_Drug_firm_hit_for_=91bribe=92_=28Philippines_v?= =?WINDOWS-1252?Q?._Pfizer=29?=   Judit Rius Sanjuan
• [Ip-health] =?windows-1252?Q?Congress=92_=241=2E2_Million_a_Day_Dr?= =?windows-1252?Q?ug_Habit_-_and_Pharma=92s_Phony_=91Gift=92_?= =?windows-1252?Q?to_Health_Care_Reform?=   Joana Ramos
• [Ip-health] =?windows-1252?Q?Opinion=3A_Obama=2C_the_drugmakers=2C_p?= =?windows-1252?Q?rofit_and_=91reform=92?=   Sarah Rimmington
• [Ip-health] =?WINDOWS-1252?Q?Re:_[Ip-health]_Congress_Should_Not_Adopt_=93No?= =?WINDOWS-1252?Q?_Generics=94_Proposals_for_Biologics:_Evergreen?= =?WINDOWS-1252?Q?ing_and_the_Creation_of_Perpetual_Marketing_Mon?= =?WINDOWS-1252?Q?opolies?=   Biotech. Info. Inst.
• [Ip-health] A letter to DG, WHO - Pneumococcal vaccine   Gopal Dabade
• [Ip-health] A Multi-Prong Strategy to Kill Generic Drugs industry   Gopa Kumar
• [Ip-health] A Pound of Cure... Too bad the medical industry has a vested interest in inefficiency   Joana Ramos
• [Ip-health] A Trips-plus agenda at WIPO   Sangeeta
• [Ip-health] AFP: Philippines sets price ceilings on 'essential' drugs   Thiru Balasubramaniam
• [Ip-health] AIDS Treatment in Brazil: Impacts and Challenges   Elize Massard
• [Ip-health] AMA J Ethics: Patents, Pricing, and Access to Essential Medicines in Developing Countries   Matt Price
• [Ip-health] Argentina, Brazil Question Swine Flu Vaccine Patents   peter maybarduk
• [Ip-health] Arroyo signs EO halving cost of 5 vital drugs   Intal - Wim De Ceukelaire
• [Ip-health] Arroyo signs EO halving cost of 5 vital drugs   Intal - Wim De Ceukelaire
• [Ip-health] Bate: Bate: India Patent Rights and Wrongs   robert weissman
• [Ip-health] BBC: "Drug firms 'must pool patents'   Thiru Balasubramaniam
• [Ip-health] Best Selling Drugs Will Soon be Biologics, But Not Owned by Biotechs says Reuters   Sarah Rimmington
• [Ip-health] Big Pharma warns Philippines over price curbs   robert weissman
• [Ip-health] BIO's press release on Eshoo/Barton biosimilar amendment   James Love
• [Ip-health] Biotech firms lobby for say on healthcare: $66m effort to protect drug-patent exclusivity   James Love
• [Ip-health] Breaking news: WHO personnel changes (Denis Aitken, Elil Renganathan, Precious Matsoso)   Thiru Balasubramaniam
• [Ip-health] Broken promise by President Obama on parallel trade in pharmaceuticals   Malini Aisola
• [Ip-health] Broken promise by President Obama on parallel trade in pharmaceuticals   Malini Aisola
• [Ip-health] Businessweek opinion: How Biotech Hurts Health Care   Sarah Rimmington
• [Ip-health] Call For Abstracts: Global Health and Innovation Summit at Yale   Jennifer Staple
• [Ip-health] Canada's Access to Meds Regime Flops   Sarah Rimmington
• [Ip-health] Cancer care and health care reform-- what are the facts?   Joana Ramos
• [Ip-health] Chronicle of Higher Education: Medical Students Assail Research Universities Over Drug-Exclusivity Bill   Ethan Guillen
• [Ip-health] Congress Should Not Adopt =?windows-1252?Q?=93No_Generics=94_?= =?windows-1252?Q?Proposals_for_Biologics=3A_Evergreening_and_t?= =?windows-1252?Q?he_Creation_of_Perpetual_Marketing_Monopolies?=   Sarah Rimmington
• [Ip-health] Congress should reject the 12-14.5 year monopoly for biologic products provided for in HR 1548   James Love
• [Ip-health] Consumer & Health Groups, State Legislators, Experts React to Vote to Add Generic Biotech Drug Proposal to Health Care Reform Bill   Sarah Rimmington
• [Ip-health] Consumer & Public Health Groups, State Legislators Ask Congress To Oppose Biogenerics Proposal   Sarah Rimmington
• [Ip-health] Cynthia Ho, Thailand CL article   Aidan Hollis
• [Ip-health] Dying for Drugs: Forgotten Children in the Developing World   Eowynne Feeney
• [Ip-health] EA comments on ACTA submitted to Canadian government   peter maybarduk
• [Ip-health] Ellen 't Hoen's presentation during the ECOSOC 2009 innovation fair   UNITAID Medicines Patent Pool Initiative
• [Ip-health] Eshoo and Barton team up to block generic biologic medicines   James Love
• [Ip-health] EU Commission adopts Final Report on Competition Inquiry   Judit Rius Sanjuan
• [Ip-health] EU-India draft Free Trade Agreement   Thiru Balasubramaniam
• [Ip-health] Examiner, Lawrence Gist: Potential plans to criminalize generic medicines could hurt the poor   Malini Aisola
• [Ip-health] Financial Times- Drug groups to reap swine-flu billions   Terri - Louise Beswick
• [Ip-health] Financial Times- Drug groups to reap swine-flu billions   Biotech. Info. Inst.
• [Ip-health] Financial Times- Drug groups to reap swine-flu billions   Biotech. Info. Inst.
• [Ip-health] Financial Times: Call for action on HIV drug patents   Thiru Balasubramaniam
• [Ip-health] Financial Times: Levy for air travellers to fight Aids   Thiru Balasubramaniam
• [Ip-health] For Immediate Release: Launch Today of Global Chagas Disease Campaign by DNDi and MSF   Drugs for Neglected Diseases initiative
• [Ip-health] Fundraiser Thursday in Washington, DC: Universities Allied for Essential Medicines   Sarah Sorscher
• [Ip-health] Fw: MSF invite for upcoming Satellite at IAS Cape Town on Access to Treatment and the Challenges of Long-Term Survival on Antiretrovirals   Leyla.POPE@geneva.msf.org
• [Ip-health] GlaxoSmithKline agrees royalty-free licensing deal for HIV drug   Judit Rius Sanjuan
• [Ip-health] Guardian: [United Kingdom] International development minister urges firms to pool HIV patents   Thiru Balasubramaniam
• [Ip-health] HAI Members' public comments to the Canadian government on ACTA negotiations   Terri - Louise Beswick
• [Ip-health] Health Insurers Fight a Public Plan, but Rarely Each Other: Studies show health insurance is one of the least competitive markets in the U.S.....   Joana Ramos
• [Ip-health] Howard Dean -- Now a shill for BIO   Malini Aisola
• [Ip-health] Howard Dean Claims He Is "Actually Not a Shill For the BIO." Then Stop Acting Like One   Malini Aisola
• [Ip-health] Howard Dean Dismisses Criticism Of Work For Biotech   James Love
• [Ip-health] Howard Dean: =?UTF-8?Q?=E2=80=9CI=E2=80=99m?= actually not a shill for the bio =?UTF-8?Q?industry=E2=80=9D?=   Malini Aisola
• [Ip-health] Huffington Post, James Love: Joe Trippi admits he works for BIO, while he plugs BIO bill in Huffpo   Malini Aisola
• [Ip-health] In the End, the Purse may not open for All: NGOs express Doubts about the Workings of the WHO Expert Working Group on R&D Financing   Judit Rius Sanjuan
• [Ip-health] India Patent Rights and Wrongs   Joana Ramos
• [Ip-health] Indian Minister of State for External Affairs broaches seizures of generics at ECOSOC   Thiru Balasubramaniam
• [Ip-health] Industry donates to Senators/Reps championing longer duration for biotech drug exclusivity   Sarah Rimmington
• [Ip-health] Indy Star: Obama asks for more from drug makers on biologis   Sarah Rimmington
• [Ip-health] Innovation in Brazil, India and South Africa: A New Drive for Economic Growth and Development   Ahmed Abdel Latif
• [Ip-health] Intellectual Property and Access to Antiretroviral Medications: Opportunities for South-to-South Cooperation as a Panel Discussion at IAS 2009   Francisco Viegas Neves da Silva
• [Ip-health] IP-Watch: Rumoured New US Ambassador to UN in Geneva A Major Obama Fundraiser   Thiru Balasubramaniam
• [Ip-health] KEI statement on adoption of Eshoo/Barton amendment   James Love
• [Ip-health] Kenya Pressured To Implement Anti-Counterfeit Law Despite Access Fears   Sarah Rimmington
• [Ip-health] Kenyan AIDS Patients Seek To Overturn Anti-Counterfeiting Law As Unconstitutional   Sarah Rimmington
• [Ip-health] Key democrats back BIO industry against consumers to delay generic medicines   Judit Rius Sanjuan
• [Ip-health] Korea-EU free trade deal announced   Heesob Nam
• [Ip-health] Le Temps (Swiss paper) on nominee for US Ambassador to United Nations (Geneva)   Thiru Balasubramaniam
• [Ip-health] Life before pharmaceutical profits! Patents can be deadly. - Signature campaign   Christiane Fischer
• [Ip-health] Margaret Chan on "new intitiaves, and new incentive schemes"   Thiru Balasubramaniam
• [Ip-health] Medical Ethics   PiterDe Vries
• [Ip-health] MSF paper says new global subsidy for malaria medicines must ensure quality of care   Leyla.POPE@geneva.msf.org
• [Ip-health] New group to to promote "the values of collaboration between medicine and industry."   Joana Ramos
• [Ip-health] New ICTSD publication: Innovation and Technology Transfer to Address Climate Change: Lessons from the Global Debate on IP and Public Health   Ahmed Abdel Latif
• [Ip-health] New ICTSD publication: Technology Transfer in the TRIPS Age: The Need for New Types of Partnerships between the Least Developed and Most Advanced Economies   Ahmed Abdel Latif
• [Ip-health] New IGH disc paper: on contracts with HIF registrants   Aidan Hollis
• [Ip-health] News Release: Big Pharma Close to Hijacking Healthcare Reform with Biogeneric Drug Proposal   Sarah Rimmington
• [Ip-health] NGO Letter to USTR on transparency: 21 Specific Recommendations   Malini Aisola
• [Ip-health] NGO Letter to USTR on transparency: 21 Specific Recommendations   Malini Aisola
• [Ip-health] Novartis loses battle for cancer drug patent   Joana Ramos
• [Ip-health] Novartis not ready to give up on Glivec   Joana Ramos
• [Ip-health] NYT: More Cost Cuts Sought From Drug Industry   Sarah Rimmington
• [Ip-health] Obama's Africa Policy - A Response to the Ghana Speech   Sisule F. Musungu
• [Ip-health] Op-Ed: Eshoo amendment will give too much protection to biotech   Sarah Rimmington
• [Ip-health] Patents will only benefit patients, claim drug cos   Joana Ramos
• [Ip-health] Peter Lee: patent commons   Aidan Hollis
• [Ip-health] Pfizer shifts more money to Democrats   James Love
• [Ip-health] Pharma giant loses legal battle   Gopal Dabade
• [Ip-health] Philippines: Arroyo 'in no hurry' to sign EO on cheaper medicines, exec says   Intal - Wim De Ceukelaire
• [Ip-health] Philippines: Pfizer =?UTF-8?Q?=E2=80=98bribe=E2=80=99?= case brought before US =?UTF-8?Q?gov=E2=80=99t?= - EO on cheap medicines takes effect Aug. 15   Wim De Ceukelaire
• [Ip-health] Pls sign! for trade advisory committees; hearing July 21   Ellen Shaffer
• [Ip-health] Pope Benedict XVI encyclical letter denounces excessive zeal for assertions of intellectual property rights in knowledge   Meredith Filak
• [Ip-health] Presentations of UNITAID's HIV/AIDS Medicines Patent Pool Briefing for Delegates to the 62nd World Health Assembly on 20th May 2009   Marie Boroli Salmon
• [Ip-health] Press release- EU negotiators are trading away Access to Medicines in Andean countries   Terri - Louise Beswick
• [Ip-health] PRESS RELEASE: SciDev.Net explores how reducing forest emissions can help tackle climate change   SciDev.Net
• [Ip-health] Procurement - USPTO Intellectual Property Initiative   James Love
• [Ip-health] PTI: Manufacturing capacity of H1N1 vaccine inadequate: WHO   Malini Aisola
• [Ip-health] Publication and event about Intellectual Property Rights and Access to ARV Medicines: Civil Society Resistance in the Global South   Francisco Viegas Neves da Silva
• [Ip-health] Reminder Today - The UNITAID HIV/AIDS Medicines Patent Pool Initiative at ECOSOC 2009 Innovation Fair   Marie Boroli
• [Ip-health] Reports: Pharma/Bio on pace to obliterate their total lobbying record; they spend even more in 2nd quarter than in first   Sarah Rimmington
• [Ip-health] Roanoke Times: Don't hand Big Pharma a windfall   Sarah Rimmington
• [Ip-health] Senate panel backs 12 year data exclusivity for biologics   Sarah Rimmington
• [Ip-health] Sign on letter to support the Federal Research Public Access Act (S.1373)   Manon Ress
• [Ip-health] Speech of WHO DG Margaret Chan to WIPO Conference: Strengthening multilateral cooperation on intellectual property and public health Address at the World Intellectual Property   Thiru Balasubramaniam
• [Ip-health] Statement from ACTA meeting in Morocco July 2009   Rachel Kiddell-Monroe
• [Ip-health] STUDENT GROUPS AND CONSUMER ADVOCATES DEMAND WITHDRAWAL OF UNIVERSITY SUPPORT FOR HARMFUL LEGISLATION   Anjali Dalal
• [Ip-health] Summary of ACTA consultations with G of Canada on 30 June   Rachel Kiddell-Monroe
• [Ip-health] Swine Flu Vaccine: Call for Patent Rights Exception   Sophie Bloemen
• [Ip-health] Syngenta AG on patent pools and prizes   Thiru Balasubramaniam
• [Ip-health] TAC and Act Up-Paris's protest in Cape Town (Eng then Fr)   jeromemartin@samizdat.net
• [Ip-health] Taxing Health Insurance Premiums and Subsidizing Health Care Providers   Nicole Woo
• [Ip-health] The Lancet supports HIV/AIDS medicines patent pool   UNITAID Medicines Patent Pool Initiative
• [Ip-health] The Nation: Democrats Go to Bat for Big Pharma   Sarah Rimmington
• [Ip-health] The UNITAID HIV/AIDS Medicines Patent Pool Initiative at ECOSOC 2009 Innovation Fair   Marie Boroli
• [Ip-health] The WIPO Conference on IP and Public Policy - A Preview   Sisule F. Musungu
• [Ip-health] Thesis on Politics of IPR in Developing Countries   Barbara van Paassen
• [Ip-health] TUES 07/14: HOUSE HEARING Biologics and Biosimilars: Balancing Incentives for Innovation   Sarah Rimmington
• [Ip-health] U.S.: Strong stand on pay-for-delay on drugs   Meredith Filak
• [Ip-health] UNITAID Liaison Officer post - please advertise widely (with caveat that person has to be registered to be able to work in the UK and there are no relocation costs)   RDoble@oxfam.org.uk
• [Ip-health] UNITAID STATEMENT ON NEW REPORT BY UK ALL PARLIAMENTARY GROUP ON AIDS - 'THE TREATMENT TIMEBOMB'   Marie Boroli
• [Ip-health] USA Today: Lobbyists battle over drug sales   Thiru Balasubramaniam
• [Ip-health] USTR's weekly newsletter on their annual GSP review   Mike Palmedo
• [Ip-health] Wall Street Journal: Drug Firms See Poorer Nations as Sales Cure   Kevin Outterson
• [Ip-health] Wall Street Journal: Drug Firms See Poorer Nations as Sales Cure   Thiru Balasubramaniam
• [Ip-health] Wall Street Journal: Philippines President Arroyo Orders Drug Price Controls   Thiru Balasubramaniam
• [Ip-health] WaPo: With Health Reform, Waxman Takes On Another Tall Order   Sarah Rimmington
• [Ip-health] Wash Post editorial: Biotech Bottleneck- Congress can encourage competition within an increasingly important class of prescription drugs.   Sarah Rimmington
• [Ip-health] Washington Post editorial: Dangerous Side Effects   Malini Aisola
• [Ip-health] Waxman Op-Ed: Limit pharma monopolies on biotech drugs to make them affordable   Sarah Rimmington
• [Ip-health] White House: ACTA still "secret in the interest of national defense or foreign policy"   James Love
• [Ip-health] WHO releases sketchy report on second meeting of Expert Working Group on R&D Financing   Malini Aisola
• [Ip-health] WIPO Development Agenda Book Launch Programme - 10 July 2009   Sisule F. Musungu
• [Ip-health] Working Group on Intellectual Property of REBRIP welcomes the patent rejection for the antiretroviral Tenofovir in Brazil   Francisco Viegas Neves da Silva
• [Ip-health] WSJ: Big Pharma Winning Most of What it Wants in HealthCare Debate   Sarah Rimmington
• [Ip-health] WSJ: Blood Boils Over Bill To Protect Biotech Drugs   Sarah Rimmington

Last message date: Fri Jul 31 18:43:01 2009
Archived on: Fri Jul 31 17:43:01 2009

• Messages sorted by: [ thread ] [ author ] [ date ]
• More info on this list...